This Solicitation opportunity from Department Of Defense was posted on September 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
DEXTROSE AND SODIUM CH
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract is for the procurement of Dextrose and Sodium Chloride Injection, a sterile, nonpyrogenic, and latex-free solution for intravenous use. Each 1,000 ml bag contains 5g of hydrous dextrose and 0.45g of sodium chloride. The product is issued in packages of 12 bags and must be stored at controlled room temperatures between 20 to 25 degrees Celsius. The item is regulated by the FDA and carries a non-extendable shelf life of 30 months. The order consists of one box under NSN 6505001161025, with delivery required within 10 days to Fort Drum, New York. Compliance with DLA packaging requirements, MIL-STD-129 marking, and Medical Marking Standard No. 1 is mandatory. The shipment must be sent via the fastest traceable means, avoiding parcel post, with a required delivery date of September 4, 2026.
General Info
Agency
NAICS
Place of Performance
BLDG 4486 CAMP SWIFT ROAD, FORT DRUM, NY, 13602-5000, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
DEXTROSE AND SODIUM CHLORIDE INJECTION<(>,<)> USP. RX ONLY; STERILE AND
NONPYROGENIC. SINGLE-DOSE CONTAINER. LATEX-FREE; CONTAINS DEHP. FOR
INTRAVENOUS USE ONLY. CONTAINS ONE PORT. EACH 100 ML CONTAINS: HYDROUS
DEXTROSE USP 5 G SODIUM CHLORIDE USP 0.45 G WATER FOR INJECTION USP QS.
UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (BAGS/CONTAINERS). EACH
BAG OR CONTAINER CONTAINS 1,000 ML OR 1 LITER. STORE AT 20 TO 25°C (68
TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] AVOID EXCESSIVE HEAT
AND PROTECT FROM FREEZING. USE ONLY IF THE SOLUTION IS CLEAR AND SEALS
ARE INTACT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7926-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018150233 0001 BX 1.000
SPE2DP-26-T-4875
SECTION B
PR: 7018150233 PRLI: 0001 CONT’D
NSN/MATERIAL:6505001161025
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W810DR
0548 CS BN CO A COMPOSITE
AWCF SSF
BLDG 4486 CAMP SWIFT ROAD
FORT DRUM NY 13602-5000
US
RDD 555 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W810DR
0548 CS BN CO A COMPOSITE
AWCF SSF
BLDG 4486 CAMP SWIFT ROAD
FORT DRUM NY 13602-5000
US
MARKFOR
W810DR
0548 CS BN CO A COMPOSITE
AWCF SSF
BLDG 4486 CAMP SWIFT ROAD
FORT DRUM NY 13602-5000
US
M/F: (TCN) W810DR62430159
RDD: 555
PROJ: TP 2
SPE2DP-26-T-4875
SECTION B
PR: 7018150233 PRLI: 0001 CONT’D
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/04/2026
SPE2DP-26-T-4875 NSN/Part Number: 6505-00-116-1025 Quantity: 1 BX Purchase Request: 7018150233QTY: 1 Delivery: 10 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS